For extended therapy of more than eight cycles, bortezomib for injection may be administered on the standard schedule or for relapsed multiple. Dailymed bortezomib injection, powder, lyophilized, for. It is the first in the class of drugs called proteasome inhibitors. A summary of the current regulatory status of velcade is provided in table 1 below. See actual entry in rtecs for complete information. Qualititative and quantitative composition velcade bortezomib is an antineoplastic agent for intravenous injection iv or subcutaneous sc use only. Learn about effective strategies used to reduce injection site reactions that can occur with sc delivery. Bortezomib hospira, innbortezomib european medicines agency. It is generally used together with other medications. Inject the solution as a three to five second bolus intravenous injection through a peripheral or central intravenous catheter into a vein. Velcade bortezomib is being used as a single agent as second line therapy for relapsed, refractory, or progressive disease or as less aggressive induction therapy with vrcap bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone regimen. Definition from the nci drug dictionary detailed scientific definition and other names for this drug. Velcade bortezomib for injection prescribing information. Mantle cell lymphoma is a type of blood cancer that affects white blood cells called lymphocytes.
Targeted therapy is the result of about 100 years of research dedicated to understanding the differences between cancer cells and normal cells. The most common finding is a 2cm to 3cm area of hyperpigmentation at the injection site with or without pruritus, which is selflimiting and resolves over a period of days to weeks figure 1. Velcade is administered first followed by rituximab. Understanding velcade bortezomib injection will familiarize you with. Bortezomib sun, innbortezomib european medicines agency.
Dec 21, 2019 bortezomib msds pdf bortezomib for injection. For bortezomib for injection related neuropathic pain andor peripheral neuropathy, hold or modify bortezomib for injection as outlined in table 5. The imf is dedicated to improving the quality of life of. After reconstitution, 1 ml of solution for subcutaneous injection contains 2.
Questions for your healthcare team at takeda oncology, we believe that being an active participant in your treatment plan helps you get more out of your doctors appointments. For the use of registered medical practitioner or hospital or. It will also assess the effect of bortezomib treatment on patient bone health. Highlights of prescribing information closely monitor. If you have questions about this medicine talk to your doctor, pharmacist, or health care provider. Find patient medical information for velcade injection on webmd including its uses, side effects and safety, interactions, pictures, warnings and user ratings. This corresponds to the mode of administration of the reference medicinal product velcade 3. Read all of this leaflet carefully before you start using this medicine because it contains important information for you. Prescribing information and velcade reimbursement assistance program vrap application.
The chemical name for bortezomib, the monomeric boronic acid, is 1r3methyl12s1oxo3phenyl2pyrazinylcarbonyl aminopropylaminobutyl boronic acid. Us package insert fdampi finalized may, 2003 1 1 millennium pharmaceuticals, inc. Jan 14, 2015 bortezomib injection price generic velcade cost usa bortezomib 3. Only select registry of toxic effects of chemical substances rtecs data is presented here. The reconstituted material may be stored in the original vial andor the syringe prior to administration. Velcade bortezomib for injection is indicated for the treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy. Neomib bortezomib for injection is an antineoplastic agent available for intravenous rapid bolus use only. Bortezomib, sold under the brand name velcade among others, is an anticancer medication used to treat multiple myeloma and mantle cell lymphoma. Consumer information about the medication bortezomib injection velcade, includes side effects, drug interactions, recommended dosages, and storage information. What bortezomib looks like and contents of the pack bortezomib powder for solution for injection is a white to offwhite cake or powder.
This includes multiple myeloma in those who have and have not previously received treatment. Bortezomib velcade in the treatment of multiple myeloma. Bortezomib interferes with the growth of some cancer cells and keeps them from spreading in your body. The aim of this trial is to determine whether bortezomib improves response and delays progression for multiple myeloma patients after high dose therapy and autologous stem cell transplant. Therapeutic goods administration auspar velcade bortezomib janssencilag pty ltd. After reconstitution, 1ml of solution for subcutaneous injection contains 2. Bortezomib is a modified dipeptidyl boronic acid which is in the form of mannitol boronic ester, reconstituted form, consists of the mannitol ester in equilibrium with its hydrolysis product, the monomeric boronic acid. Bortezomib by injection national library of medicine.
If, after bortezomib has been withheld, the toxicity does not resolve, discontinue bortezomib. Velcade bortezomib for injection, for subcutaneous or intravenous use initial u. Velcade bortezomib injection, for subcutaneous or intravenous use. Highlights of prescribing information these highlights do not include all the information needed to use velcade safely and effectively. Bortezomib is classified as a proteasome inhibitor.
Darzalex daratumumab injection, solution, concentrate janssen biotech, inc. A vial of bortezomib can be used for either sc or iv administration. Vision impaired people having problems accessing certain pages of a pdf file may call 301 7963634 for assistance. A rare form of nonhodgkin lymphoma nhl, mantle cell lymphoma makes up about 6% of all nhl cases in the united states. Medicinal product according to article 101 for bortezomib sun 3. Bortezomib hospira international nonproprietary name. Velcade is for intravenous or subcutaneous use only. Velcade is administered twice weekly for two weeks days 1, 4, 8, and 11 followed by a ten day rest period on days 12 to 21. Velcade for injection contains bortezomib which is an antineoplastic agent. Velcade bortezomib for injection, for subcutaneous or intravenous use. Us package insert fdampi finalized may, 2003 6 152 indications and usage 153 velcade tm bortezomib for injection is indicated for the treatment of multiple 154 myeloma patients who have received at least two prior therapies and have demonstrated 155 disease progression on the last therapy. When administered intravenously, velcade is administered as a 3 to 5 second bolus intravenous injection.
Cure 7 myeloma most often grows in the marrow within the bones of the spine, skull, pelvis, rib cage, shoulders. Administer reconstituted bortezomib for injection within 8 hours of preparation. In some cases, health care professionals may use the trade name velcade when referring to the generic drug name bortezomib. Jun 07, 2019 what other drugs will affect bortezomib velcade. It gets its name because it affects lymphocytes in the mantle zone of a lymph node. Because each route of administration has a different reconstituted concentration, caution should be used. Bortezomib injection velcade side effects, medical. If you take any drugs prescription or otc, natural products, vitamins that must not be taken with bortezomib, like certain drugs that are used for hiv, infections, or seizures. Jan 31, 2020 bortezomib msds pdf bortezomib for injection. A read is counted each time someone views a publication summary such as the title, abstract, and list of authors, clicks on a figure, or views or downloads the fulltext. If local injection site reactions occur following bortezomib injection subcutaneously, either a less concentrated bortezomib solution 1mgml instead of 2.
Velcade is frequently combined with the monoclonal antibody rituxan or with rituxan and dexamethasone for the treatment of wm. Velcade, in combination with melphalan and prednisone, is indicated for the treatment of patients. Find patient medical information for bortezomib injection on webmd including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Janssencilags other registered velcade product, a 1 mg bortezomib powder for injection, is not part of this application. The fda has approved it for the treatment of multiple myeloma. Velcade bortezomib for injection ordering and billing. Bortezomib powder for solution for injection is a white to offwhite cake or powder. Velcade bortezomib is an antineoplastic agent for intravenous injection iv or subcutaneous sc use only. Velcade bortezomib dosing, indications, interactions. When reconstituted as directed, bortezomib for injection may be stored at 25c 77f. This randomised, phase 3 study was undertaken at 53 centres in ten countries in europe, asia, and south america. If toxicity resolves such that the patient has an anc at or above 0.
Bortezomib velcade, a reversible proteasome inhibitor, is approved by the us food and drug administration fda for intravenous iv or subcutaneous sc injection in patients with multiple myeloma or those with mantle cell lymphoma who have received at least one prior therapy millennium pharmaceuticals, inc. In addition, bortezomib appears to increase the sensitivity of cancer cells to traditional anticancer agents e. Velcade is given as an infusion into a vein intravenous, iv or as a subcutaneous under the skin injection into the thigh or abdomen. Highlights of prescribing information these highlights do not include all the information needed to use darzalex safely and effectively. Osha hazardous drugs refer to antineoplastic weblinks including osha technical manual. In h460 cell lines, bortezomib induced bcl2 phosphorylation and a unique cleavage product and this was associated with g 2 m phase cell cycle arrest and the induction of apoptosis. Aug, 2019 bortezomib msds pdf bortezomib for injection. Proposal for the inclusion of bortezomib, lenalidomide or. The introduction of bortezomib, a novel firstinclass proteasome inhibitor, has been a major break through in the treatment of multiple myeloma. Tell your doctor about the allergy and what signs you had. Bortezomib injection velcade side effects, medical uses.
Velcade should not be administered by any other route. Velcade bortezomib side effects, images, uses, dosage. Read more about the prescription drug bortezomib injection. Ics will be the managing the ordering, distribution, shipment, and monitoring of velcade.
It is currently approved for the treatment of myeloma in the relapsed setting post transplant or as a second. Velcade bortezomib is approved for the treatment of adults with multiple myeloma a cancer of the plasma cells. For extended therapy of more than 8 cycles, velcade may be administered on the standard schedule or on a maintenance schedule of once. If several bortezomib doses in consecutive cycles are withheld due to toxicity. Patients aged 18 years and older with relapsed multiple myeloma after one to three previous lines of therapy were randomly assigned to receive up to eight 21day cycles of bortezomib mgm 2, on days 1, 4, 8, and 11, by subcutaneous injection or intravenous infusion. Bortezomib for injection contains no antimicrobial preservative. Subcutaneous versus intravenous administration of bortezomib.
Since the growth of normal body cells may also be affected by bortezomib, other effects will also. Jun 07, 2019 velcade bortezomib injection, for subcutaneous or intravenous use. Velcade is also approved for the treatment of adults with mantle cell lymphoma a cancer of the lymph nodes. State and local taxes may apply in certain states and are the responsibility of the order placing party. Bortezomib injection is used to treat multiple myeloma blood plasma cell cancer in patients with or without a prior history of treatment, and mantle cell lymphoma bortezomib interferes with the growth of cancer cells, which are then eventually destroyed by the body. Velcade fact sheet last update 11282015 how velcade works. Millenniumdirect is the distribution channel for velcade bortezomib for injection. If you have any further questions, ask your doctor, hospital pharmacist or nurse.
Bortezomib is also being studied in the treatment of other types of cancer. Velcade is prescribed by a doctor experienced in the use of medications to treat cancer. Bortezomib is associated with a low rate of serum enzyme elevations during treatment and to rare. Bortezomib is used to treat multiple myeloma and mantle cell lymphoma. In cycles 14, bortezomib accord is administered twice weekly on days 1, 4, 8, 11, 22, 25, 29 and 32. Flush the peripheral or intravenous catheter with sterile, 9mgml 0. Nov 22, 2019 bortezomib for injection contains no antimicrobial preservative.
The imfs reach extends to more than 525,000 members in 140 countries worldwide. Bortezomib sun is administered via intravenous or subcutaneous injection at the recommended dose of 1. Hospira bortezomib powder for injection is also indicated for the treatment of multiple myeloma patients who have received at least one prior. What is integrated commercialization services icss role in the distribution of velcade bortezomib for injection. Bortezomib velcade is approved by the fda for iv or sc injection in select patients with multiple myeloma or mantle cell lymphoma. The sc route functions as an alternative to iv administration for patients with poor iv access.
Bortezomib is a proteasome inhibitor and antineoplastic agent that is used in treatment of refractory multiple myeloma and certain lymphomas. Withhold bortezomib until symptoms resolve to grade 1 or baseline. Proposal for the inclusion of bortezomib, lenalidomide and thalidomide in the who model list of essential medicines for the firstline treatment of. Nov 01, 2012 injection site reactions are common but generally mild with sc administration of bortezomib.
Mar 08, 2020 bortezomib msds pdf bortezomib for injection. Mantle cell lymphoma in patients who have already received at least one other type of treatment. Janssencilag pty ltd proposes to register a new route of administration sc injection for their velcade 3. The molecular aspects that the article addressed was the mechanism by which bortezomib regulates the bcl2 family of proteins.
665 994 20 508 791 35 1246 276 226 1142 1571 1269 93 1445 781 1531 1374 372 635 407 1578 1143 159 1349 165 841 606 717 903 632 270 752 1628 684 629 365 913 620 72 345 968 649 209 957 622